TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmaxim AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
15,726
|
13,775
|
17,851 |
| Financial expenses |
82
|
38
|
21 |
| Earnings before taxes |
1,051
|
838
|
813 |
| EBITDA |
1,169
|
885
|
904 |
| Total assets |
8,183
|
8,234
|
8,559 |
| Current assets |
5,401
|
5,710
|
5,740 |
| Current liabilities |
2,552
|
4,281
|
3,891 |
| Equity capital |
4,044
|
3,696
|
4,307 |
| - share capital |
104
|
103
|
112 |
| Employees (average) |
14
|
15
|
16 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
49.4%
|
44.9%
|
50.3% |
| Turnover per employee |
1,123
|
918
|
1,116 |
| Profit as a percentage of turnover |
6.7%
|
6.1%
|
4.6% |
| Return on assets (ROA) |
13.8%
|
10.6%
|
9.7% |
| Current ratio |
211.6%
|
133.4%
|
147.5% |
| Return on equity (ROE) |
26.0%
|
22.7%
|
18.9% |
| Change turnover |
1,911
|
-2,630
|
-1,994 |
| Change turnover % |
14%
|
-16%
|
-10% |
| Chg. No. of employees |
-1
|
-1
|
-4 |
| Chg. No. of employees % |
-7%
|
-6%
|
-20% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.